von vigilantbio | Apr 27, 2023 | Pressemitteilung
LAKEWAY, Texas (April 27, 2023) — Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection of oral cancer, is proud to announce receipt of Breakthrough Device Designation from the Food and Drug...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES